Indivior | Kortfristiga Skulder



Current Liabilities Ändra Datum
AstraZeneca USD 27.87B 1.94B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Glaxosmithkline GBP 21.7B 238M 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Indivior 962M 50M 2024-09
J&J USD 50.32B 1.44B 2024-12
Kyowa Hakko Kirin JPY 164.68B 8.99B 2024-12
Merck USD 28.42B 1.17B 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Sanofi 30.03B 5.82B 2024-06
Supernus Pharmaceuticals USD 292.4M 889K 2024-12



Indivior Kortfristiga Skulder - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.